Tice® BCG (for intravesical use) BCG LIVE strain of the BCG (Merck) vaccine
USUHS.2020-062
Phase 3 small_molecule terminated
Quick answer
Tice® BCG (for intravesical use) BCG LIVE strain of the BCG (Merck) vaccine for COVID-19 is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- COVID-19
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated